kf 17837s has been researched along with cytidylyl-3',5'-adenosine in 1 studies
Studies (kf 17837s) | Trials (kf 17837s) | Recent Studies (post-2010) (kf 17837s) | Studies (cytidylyl-3',5'-adenosine) | Trials (cytidylyl-3',5'-adenosine) | Recent Studies (post-2010) (cytidylyl-3',5'-adenosine) |
---|---|---|---|---|---|
39 | 0 | 0 | 37 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dubey, RK; Gillespie, DG; Jackson, EK; Shue, H | 1 |
1 other study(ies) available for kf 17837s and cytidylyl-3',5'-adenosine
Article | Year |
---|---|
A(2B) receptors mediate antimitogenesis in vascular smooth muscle cells.
Topics: 2-Chloroadenosine; Adenine; Adenosine; Adenosine Kinase; Adenosine-5'-(N-ethylcarboxamide); Animals; Anticoagulants; Antihypertensive Agents; Aorta, Abdominal; Becaplermin; Cell Division; Dinucleoside Phosphates; Enzyme Inhibitors; Hyperplasia; Male; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Oligonucleotides, Antisense; Phenethylamines; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-2; Thymidine; Tritium; Tubercidin; Vasodilator Agents; Xanthines | 2000 |